Substituted diazepan orexin receptor antagonists
US8362009B2 · kind B2 · utility
27Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2008 |
| Grant date | Jan 29, 2013 |
| Priority date | — |
| Expiry date | Jun 11, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to diazepan compounds which are antagonists of orexin receptors, and which are useful in the treatment of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which orexin receptors are involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.